<DOC>
	<DOCNO>NCT00285623</DOCNO>
	<brief_summary>The purpose study collect information , exposure TachoSil ® , thromboembolic event , immunological event drug interaction lead thromboembolic event major bleed . In addition , pharmacoeconomic data collect .</brief_summary>
	<brief_title>Observational Cohort Study TachoSil ( TC-018-IN )</brief_title>
	<detailed_description />
	<mesh_term>Blood Loss , Surgical</mesh_term>
	<mesh_term>Thrombin</mesh_term>
	<criteria>All subject , treat TachoSil ® participate physician , register set basic data already exist data ( i.e . additional diagnostic procedure perform ) . Subjects provide write informed consent use exist data , allow direct access data data processing .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>July 2009</verification_date>
	<keyword>Collection thromboembolic event ,</keyword>
	<keyword>immunological event drug interaction lead thromboembolic event major</keyword>
	<keyword>bleed exposure TachoSil® .</keyword>
</DOC>